Vitamin D pathway gene variants and prostate cancer prognosis
The Prostate2010Vol. 70(13), pp. 1448–1460
Citations Over TimeTop 10% of 2010 papers
Sarah K. Holt, Erika M. Kwon, Joseph S. Koopmeiners, Daniel W. Lin, Ziding Feng, Elaine A. Ostrander, Ulrike Peters, Janet L. Stanford
Abstract
Genetic variations in vitamin D pathway genes were found to alter both risk of recurrence/progression and PCa-specific mortality.
Related Papers
- → Expression of the vitamin D receptor, 25-hydroxylases, 1α-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer(2010)83 cited
- → Vitamin D receptor (VDR) and metabolizing enzymes CYP27B1 and CYP24A1 in breast cancer(2020)43 cited
- → Role of local bioactivation of vitamin D by CYP27A1 and CYP2R1 in the control of cell growth in normal endometrium and endometrial carcinoma(2014)47 cited
- → Effects of 1,25 and 24,25 Vitamin D on Corneal Fibroblast VDR and Vitamin D Metabolizing and Catabolizing Enzymes(2021)10 cited
- → Anticancer activity of vitamin D – molecular mechanisms(2020)1 cited